EMA sets up expert group on medicine innovation
The European Medicines Agency (EMA) has established a Quality Innovation Expert Group (QIG) to support innovative approaches for the development, manufacture, and quality control of medicines for the benefit of patients in the EU. These include new technologies, digitalisation, novel materials and novel devices. The role of the QIG is to ensure that the European medicines regulatory network keeps pace with innovation, […]
Recent Comments